Market Cap 2.46B
Revenue (ttm) 0.00
Net Income (ttm) -182.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 604,400
Avg Vol 667,452
Day's Range N/A - N/A
Shares Out 46.11M
Stochastic %K 26%
Beta 1.43
Analysts Strong Sell
Price Target $94.30

Company Profile

Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications. The company develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for the treatment of AD, which is in phase 2 clinical trials; and for the treatment of asthma and EoE which is in phase 1 clinical t...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 394 5230
Address:
Building 17, Suite 102b 221 Crescent Street, Waltham, United States
BEATOFtheMARKET
BEATOFtheMARKET Oct. 24 at 10:24 PM
0 · Reply
JarvisFlow
JarvisFlow Oct. 21 at 12:43 PM
Mizuho has adjusted their stance on Apogee Therapeutics ( $APGE ), setting the rating to Outperform with a target price of 105.
0 · Reply
Rvazstocksfl
Rvazstocksfl Oct. 21 at 12:27 PM
$APGE wow 🤩
0 · Reply
Pika_Capital
Pika_Capital Oct. 14 at 2:44 PM
$ORKA $APGE $SYRE reminder
0 · Reply
Pika_Capital
Pika_Capital Oct. 14 at 1:21 AM
$SYRE I expect strong demand during offering as for $APGE Stock is green AH, tomorrow should be interesting
0 · Reply
Pika_Capital
Pika_Capital Oct. 11 at 12:02 PM
$PTGX proceeds will be redeployed into $IMVT, $APGE (possibly more $GMAB ) and across bunch of other names in pfolio. May reenter $BHVN again but not sure, it's a lower conviction name going into PDUFa.
2 · Reply
swampwiz0
swampwiz0 Oct. 10 at 12:25 AM
$APGE CHA-CHING AGAIN!
0 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 9:51 PM
Keep a close watch on CMCT! $APGE $BLBX $HTZ $CC !
0 · Reply
Quantumup
Quantumup Oct. 9 at 6:13 PM
BofA⬇️ $APGE's PT to $82 from $89 to reflect Wednesday's capital raise—made no changes to APG777 launch timing or PoS assumptions; Reiterated Buy. $REGN $SNY BofA said: Next catalysts in 1Q after development timeline updates APGE has narrowed guidance for the following APG777 (IL-13) readouts: 1) AD Ph 2 Part A 52-week maintenance readout now expected in 1Q26 (vs 1H-2026 previously), 2) asthma Ph 1b readout also now expected in 1Q26 (vs 1H-2026 previously), and 3) AD2 Part B 16-week readout now expected 2Q26 (vs mid-2026 previously). APGE still guides for 2029 launch. Other readouts are on track including APG279 (IL-13 + OX40Lcombination) Phlb proof of concept readout (vs. Dupixent) in AD (in 2H26) and APG777AD Ph 3 initiation (in 2H26).
0 · Reply
HodlMaBeer
HodlMaBeer Oct. 9 at 5:10 PM
0 · Reply
Latest News on APGE
Apogee Therapeutics: Engineering Biologic Dominance

Apr 14, 2025, 8:04 AM EDT - 6 months ago

Apogee Therapeutics: Engineering Biologic Dominance


Apogee Therapeutics Announces Agenda for Virtual R&D Day

Nov 29, 2024, 1:00 PM EST - 11 months ago

Apogee Therapeutics Announces Agenda for Virtual R&D Day


BEATOFtheMARKET
BEATOFtheMARKET Oct. 24 at 10:24 PM
0 · Reply
JarvisFlow
JarvisFlow Oct. 21 at 12:43 PM
Mizuho has adjusted their stance on Apogee Therapeutics ( $APGE ), setting the rating to Outperform with a target price of 105.
0 · Reply
Rvazstocksfl
Rvazstocksfl Oct. 21 at 12:27 PM
$APGE wow 🤩
0 · Reply
Pika_Capital
Pika_Capital Oct. 14 at 2:44 PM
$ORKA $APGE $SYRE reminder
0 · Reply
Pika_Capital
Pika_Capital Oct. 14 at 1:21 AM
$SYRE I expect strong demand during offering as for $APGE Stock is green AH, tomorrow should be interesting
0 · Reply
Pika_Capital
Pika_Capital Oct. 11 at 12:02 PM
$PTGX proceeds will be redeployed into $IMVT, $APGE (possibly more $GMAB ) and across bunch of other names in pfolio. May reenter $BHVN again but not sure, it's a lower conviction name going into PDUFa.
2 · Reply
swampwiz0
swampwiz0 Oct. 10 at 12:25 AM
$APGE CHA-CHING AGAIN!
0 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 9:51 PM
Keep a close watch on CMCT! $APGE $BLBX $HTZ $CC !
0 · Reply
Quantumup
Quantumup Oct. 9 at 6:13 PM
BofA⬇️ $APGE's PT to $82 from $89 to reflect Wednesday's capital raise—made no changes to APG777 launch timing or PoS assumptions; Reiterated Buy. $REGN $SNY BofA said: Next catalysts in 1Q after development timeline updates APGE has narrowed guidance for the following APG777 (IL-13) readouts: 1) AD Ph 2 Part A 52-week maintenance readout now expected in 1Q26 (vs 1H-2026 previously), 2) asthma Ph 1b readout also now expected in 1Q26 (vs 1H-2026 previously), and 3) AD2 Part B 16-week readout now expected 2Q26 (vs mid-2026 previously). APGE still guides for 2029 launch. Other readouts are on track including APG279 (IL-13 + OX40Lcombination) Phlb proof of concept readout (vs. Dupixent) in AD (in 2H26) and APG777AD Ph 3 initiation (in 2H26).
0 · Reply
HodlMaBeer
HodlMaBeer Oct. 9 at 5:10 PM
0 · Reply
Pika_Capital
Pika_Capital Oct. 9 at 4:25 PM
$ORKA $APGE $SYRE every day of waiting costs you 💰💰
1 · Reply
Pika_Capital
Pika_Capital Oct. 9 at 3:52 PM
$APGE +30% in 2 days plus offering lol. Train 🚂 is leaving the station. You are either with Pika or continue being broke
0 · Reply
CEM97
CEM97 Oct. 9 at 3:40 PM
$IMRX the stocks that have went up recently on offerings: $APGE $QURE
0 · Reply
crosby22
crosby22 Oct. 9 at 3:40 PM
$APGE where is the ceiling?
0 · Reply
MaverikIT
MaverikIT Oct. 9 at 2:55 PM
$APGE +3.78 - nice upgrade$ by BTIG
0 · Reply
OpenOutcrier
OpenOutcrier Oct. 9 at 12:42 PM
$APGE (-1.6% pre) Apogee Therapeutics prices $300 million stock offering at $41 per share - SI https://ooc.bz/l/79908
0 · Reply
DonCorleone77
DonCorleone77 Oct. 9 at 10:35 AM
$APGE Apogee Therapeutics 6.95M share Spot Secondary priced at $41.00
0 · Reply
anvesti
anvesti Oct. 9 at 2:33 AM
0 · Reply
Pika_Capital
Pika_Capital Oct. 9 at 2:15 AM
$APGE brilliant offering lol. Pumped the price and raised $300M + Short term pain but they are going to have now $900M in cash.
0 · Reply
amda
amda Oct. 8 at 9:36 PM
$APGE in at 42.60
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Oct. 8 at 9:08 PM
0 · Reply
amda
amda Oct. 8 at 8:58 PM
$APGE how can a company announce an offering without saying how many shares? was the price pop today just total manipulation? what BS....
0 · Reply